{"url_path":"/sec/apls/8-k/2026-05-14/item-1-02","section_key":"item-1-02","section_title":"Item 1.02 Termination of a Material Definitive Agreement","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1492422/0001193125-26-222923-index.html","accession_number":"0001193125-26-222923","cik":"0001492422","ticker":"APLS","issuer_name":"Apellis Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1492422/0001193125-26-222923-index.html","primary_entity_key":"0001492422","primary_entity_name":"Apellis Pharmaceuticals, Inc."},"word_count":146,"has_tables":true,"body_markdown":"Item 1.02 Termination of a Material Definitive Agreement\n\nIn connection with the consummation of the Merger, effective as of immediately prior to the Effective Time, the Company terminated its 2017 Employee Stock Purchase Plan.\n\nIn connection with the consummation of the Merger, and concurrently with the Effective Time, the Company terminated all commitments outstanding under, and repaid all outstanding loans and other amounts due under, the Financing Agreement, dated as of June 30, 2025 (and as further amended, restated, amended and restated, supplemented or otherwise modified to date, the “Financing Agreement”), by and among the Company, certain subsidiaries of the Company, as guarantors, the various lenders and other parties from time to time party thereto and Sixth Street Lending Partners, as collateral agent and administrative agent.\n\nThe information set forth in the Introductory Note of this Current Report on Form 8-K is incorporated herein by reference."}